🟢 Moleculin Biotech is trading 5.5% up in after-hours trading with no identified catalyst

Moleculin Biotech is trading 5.5% higher in after-hours trading at $0.47, versus the regular-session close of $0.45; no catalyst was identified.

• The regular session closed down 6.53% on October 6, 2026.
• Its latest listed press release, dated September 29, reported completion of enrollment in Part A of the MIRACLE trial. Its corporate presentation was dated October 5.
• No October 6 company-specific announcement was found; major indexes rose, but evidence does not link them to the after-hours move.